研究業績
研究業績2015年度 英文原著
1.Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barisic N, Brabec P, Lahdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Viswanathan V, Bayat F, Buccella F, Kimura E, Koeks Z, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Zimowski J, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Jeannet PY, Joncourt F, Diaz-Manera J, Gallardo E, Karaduman AA, Topaloglu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Bellgard MI, Kirschner J, Flanigan KM, Straub V, Bushby K, Verschuuren J, Aartsma-Rus A, Beroud C, Lochmuller H:
The TREAT-NMD DMD Global Database: Analysis of more than 7,000 Duchenne muscular dystrophy mutations.
Hum Mutat, 36: 395-402, 2015
2.Hassan WA, Udaka N, Ueda A, Ando Y, Ito T:
Neoplastic lesions in CADASIL syndrome: report of an autopsied Japanese case.
Int J Clin Exp Pathol, 8: 7533-7539, 2015
3.Hawkins PN, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr OB:
Evolving landscape in the management of transthyretin amyloidosis.
Ann Med, 47: 625-638, 2015
4.Hirahara T, Yamashita S, Misumi Y, Kawakami K, Hori H, Honda S, Watanabe M, Ikeda T, Yamashita T, Maeda Y, Ando Y:
Reply to comments on ‘gait disturbance due to foot drop is refractory to treatment in nonsystemic vasculitic neuropathy’.
Eur Neurol, 73: 80, 2015
5.Hori H, Maeda Y, Ishizaki M, Hirahara T, Watanabe M, Yamashita S, Yamashita T, Uchino M, Ando Y:
A carrier with de novo mutation in the dystrophin gene whose myopathic symptoms became seriously progressive after pregnancy and delivery.
Muscle Nerve, 52: 913-914, 2015
6.Inoue Y, Honda S, Watanabe M, Ando Y:
Educational campaigns at point of purchase in rural supermarkets improve stroke knowledge.
J Stroke Cerebrovasc Dis, 24: 480-484, 2015
7.Inoue Y, Nakajima M, Uetani H, Hirai T, Ueda M, Kitajima M, Utsunomiya D, Watanabe M, Hashimoto M, Ikeda M, Yamashita Y, Ando Y:
Diagnostic significance of cortical superficial siderosis for Alzheimer’s disease in patients with cognitive impairment.
AJNR Am J Neuroradiol, 37: 223-227, 2016
8.Iryo Y, Hirai T, Nakamura M, Inoue Y, Watanabe M, Ando Y, Azuma M, Nishimura S, Shigematsu Y, Kitajima M, Yamashita Y:
Collateral circulation via the circle of Willis in patients with carotid artery steno-occlusive disease: evaluation on 3-T 4D MRA using arterial spin labelling.
Clin Radiol, 70: 960-965, 2015
9.Ishizaki M, Fujimoto A, Ueyama H, Nishida Y, Shigehiro I, Makoto U, Ando Y:
Life-threatening arrhythmias in a Becker muscular dystrophy family due to the dupilication of exon3-4 of the dystrophin gene.
Intern Med, 54: 3075-3078, 2015
10.Ito Y, Nakajima M, Watari M, Sakamoto T, Hashimoto Y, Tajiri S, Takada A, Ando Y:
Intratumoral hemorrhage in a patient with malignant meningioma under anticoagulant therapy.
J Stroke Cerebrovasc Dis, 24: e91-e92, 2015
11.Kitagawa K, Misumi Y, Ueda M, Hayashi Y, Tasaki M, Obayashi K, Yamashita T, Jono H, Arima H, Ando Y:
Inhibition of insulin amyloid fibril formation by cyclodextrins.
Amyloid, 22: 181-186, 2015
12.Kon T, Misumi Y, Nishijima H, Honda M, Suzuki C, Baba M, Inomata Y, Obayashi K, Ando Y, Tomiyama M:
Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: A case report.
Amyloid, 22: 203-204, 2015
13.Masuda T, Ueda M, Ueyama H, Shimada S, Ishizaki M, Imamura S, Yamamoto T, Ando Y:
Megalencephalic leukoencephalopathy with subcortical cysts caused by compound heterozygous mutations in MLC1, in patients with and without subcortical cysts in the brain.
J Neurol Sci, 351: 211-213, 2015
14.Matsushima K, Sugiuchi H, Anraku K, Nishimura H, Manabe M, Ikeda K, Ando Y, Kondo Y, Ishitsuka Y, Irikura M, Irie T:
Differences in reaction specificity toward lipoprotein X and abnormal LDL among 6 homogeneous assays for LDL-cholesterol.
Clin Chim Acta, 439: 29-37, 2015
15.Mishima T, Fujioka S, Kurisaki R, Yanamoto S, Higuchi MA, Tsugawa J, Fukae J, Neshige R, Tsuboi Y:
Impulse control disorders and punding in Perry syndrome.
Parkinsonism Relat Disord, 21: 1381-1382, 2015
16.Miura Y, Devaux JJ, Fukami Y, Manso C, Belghazi M, Wong AH, Yuki N, CNTN1-CIDP Study Group (Fujimura H, Toshio Fukutake T, Iwanami H, Kusaka H, Kuwabara S, Okuma Y, Ueda M, Yamamoto T):
Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia.
Brain, 138: 1484-1491, 2015
17.Naganuma M, Inatomi Y, Kobayashi O, Nishi T, Yonehara T, Ando Y:
Reappearance of free-floating carotid thrombus after discontinuation of anticoagulant therapy.
J Stroke Cerebrovasc Dis, 24: e45-e47, 2015
18.Nakajima M, Inatomi Y, Yonehara T, Watanabe M, Ando Y:
Outcome in patients admitted outside regular hospital working hours: Does time until regular working hours matter?
Int J Stroke, 10: 79-84, 2015
19.Nakajima M, Pearce LA, Ohara N, Field TS, Bazan C, Anderson DC, Hart RG, Benavente OR:
Vertebrobasilar ectasia in patients with lacunar stroke: The SPS3 trial.
J Stroke Cerebrovasc Dis, 24: 1052-1058, 2015
20.Nakama T, Yamashita S, Hirahara T, Okamoto S, Honda S, Watanabe M, Kimura E, Uchino M, Yano S, Kuratsu J, Ando Y:
Usefulness of intraventricular infusion of antifungal drugs through Ommaya reservoirs for cryptococcal meningitis treatment.
J Neurol Sci, 358: 259-262, 2015
21.Nakamura T, Shinriki S, Jono H, Guo J, Ueda M, Hayashi M, Yamashita S, Zijlstra A, Nakayama H, Hiraki A, Shinohara M, Ando Y:
Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells.
Oncotarget, 6: 1008-1019, 2015
22.Nakamura T, Shinriki S, Jono H, Ueda M, Nagata M, Guo J, Hayashi M, Yoshida R, Ota T, Ota K, Kawahara K, Nakagawa Y, Yamashita S, Nakayama H, Hiraki A, Shinohara M, Ando Y:
Osteopontin-integrin αvβ3 axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.
FEBS Lett, 589: 231-239, 2015
23.Nakamura T, Ueda M, Takaoka H, Ando Y:
Trigeminal sensory neuropathy and mixed connective tissue disease: A case report.
Clin Case Rep Rev, 1: 130-132, 2015
24.Nishida Y, Ueda A, Ando Y, Ichikawa T:
Skin biopsy-based diagnosis of CADASIL with atypical MRI findings.
Intern Med, 54: 537-538, 2015
25.Nakane S, Yoshioka M, Oda N, Tani T, Chida K, Suzuki M, Funakawa I, Inukai A, Hasegawa K, Kuroda K, Mizoguchi K, Shioya K, Sonoda Y, Matsuo H:
The characteristics of camptocormia in patients with Parkinson’s disease: A large cross-sectional multicenter study in Japan.
J Neurol Sci, 15: 299-303, 2015
26.Sakaguchi H, Kadoshima T, Soen M, Narii N, Ishida Y, Ohgushi M, Takahashi J, Eiraku M, Sasai Y:
Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue.
Nat Commun, 17: 8896, 2015
27.Sakaguchi H, Yamashita S, Ueda A, Sada H, Ikeda T, Hirahara T, Honda S, Kimura E, Yamashita T, Maeda Y, Hirano T, Uchino M:
Chronic inflammatory demyelinating polyneuropathy triggered by interferon-α for chronic hepatitis B virus infection.
Neurol Clin Neurosci, 3: 36-38, 2015
28.Shindo S, Fujii K, Shirakawa M, Uchida K, Enomoto Y, Iwama T, Kawasaki M, Ando Y, Yoshimura S:
Morphologic features of carotid plaque rupture assessed by optical coherence tomography.
Am J Neuroradiol, 36: 2140-2146, 2015
29.Shinoda K, Taki H, Obayashi K, Ando Y, Watanabe A, Komiya A, Fuse H, Tsuneyama K, Tobe K:
Wild-type ATTR amyloidosis of the ureter in a 56-year-old woman with rheumatoid arthritis and Sjögren’s syndrome.
Int J Clin Exp Pathol, 8: 8624-8627, 2015
30.Tanabe H, Higuchi I, Maki Y, Urabe S, Obayashi K, Hokezu Y:
Myopathy in a patient with systemic AA amyloidosis induced by psoriasis vulgaris: an autopsy case.
Muscle Nerve, 52: 1113-1117, 2015
31.Tasaki M, Ueda M, Matsumoto K, Kawaji T, Misumi Y, Eiki D, Suenaga G, Obayashi K, Yamashita T, Tanihara H, Ando Y:
Clinico-histopathological and biochemical analyses of corneal amyloidosis in gelatinous drop-like corneal dystrophy.
Amyloid, 22: 67-69, 2015
32.Tokisato K, Fukunaga K, Tokunaga M, Watanabe S, Nakanishi R, Yamanaga H:
Aripiprazole can improve apraxia of eyelid opening in Parkinson’s disease.
Internal Medicine, 54: 3061-3064, 2015
33.Tokunaga M, Nishikawa M, Matsumoto A, Nanbu S, Nakagawa A, Maeda Y, Kamiyoshi M:
The relationship between measured values and values predicted using multiple regression analysis for mean motor FIM at discharge – A study at 13 Kaifukuki rehabilitation hospitals for stroke patients in the Japan Rehabilitation Database.
Jpn J Compr Rehabil Sci, 6: 86-90, 2015
34.Tokunaga M, Taniguchi M, Nakakado K, Mihono T, Okido A, Ushijima T, Eguchi G, Watanabe S, Nakanishi R, Yamanaga H:
Assessment of the effects of factors in stroke rehabilitation using eight multiple regression analyses- An analysis of the Japan Rehabilitation Database -.
Jpn J Compr Rehabil Sci, 6: 78-85, 2015
35.Toyoda K, Urasaki E, Umeno T, Sakai W, Nagaishi A, Nakane S, Fukudome T, Yamakawa Y:
The effectiveness of the stereotactic burr hole technique for deep brain stimulation.
Neurol Med Chir, 55: 766-772, 2015
36.Uchida Y, Takada K, Tsugu Y, Ueda M, Yamashita T, Ando Y, Kobayashi S, Koike H, Watanabe T, Matsumoto T, Toyoda T, Yamada G, Matsukawa N:
Two brothers homozygous for the TTR V30M both presenting with a phenotype dominated by central nervous complications.
Amyloid, 22: 261-262, 2015
37.Wada N, Kawano Y, Fujiwara S, Kikukawa Y, Okuno Y, Tasaki M, Ueda M, Ando Y, Yoshinaga K, Ri M, Iida S, Nakashima T, Shiotsu Y, Mitsuya H, Hata H:
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.
Int J Oncol, 46: 963-972, 2015
38.Watanabe M, Chaudhry SA, Muhammad MA, Majidi S, Alqadri SL, Semaan E, Qureshi AI:
The effect of atrial fibrillation on outcomes in patients undergoing carotid endarterectomy or stent placement in general practice.
J Vasc Surg, 61: 927-32, 2015
39.Yamashita S, Ando Y:
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis.
Transl Neurodegener, 4: 13, 2015
40.Yamashita S, Mori A, Nishida Y, Kurisaki R, Tawara N, Nishikami T, Misumi Y, Ueyama H, Imamura S, Higuchi Y, Hashiguchi A, Higuchi I, Morishita S, Yoshimura J, Uchino M, Takashima H, Tsuji S, Ando Y:
Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation.
Neuropathol Appl Neurobiol, 41: 391-398, 2015
41.Yanagisawa A, Ueda M, Sueyoshi T, Okada T, Fujimoto T, Ogi Y, Kitagawa K, Tasaki M, Misumi Y, Oshima T, Jono H, Obayashi K, Hirakawa K, Uchida H, Westermark P, Ando Y, Mizuta H:
Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis.
Mod Pathol, 28: 201-207, 2015
42.Yokoyama T, Ueda M, Ando Y, Mizuguchi M:
Discovery of γ-Mangostin as an Amyloidogenesis Inhibitor.
Sci Rep, 5: 13570, 2015
43.Ueda A, Ueda M, Nagatoshi A, Hirano T, Ito T, Arai N, Uyama E, Mori K, Nakamura M, Shinriki S, Ikeda K, Ando Y:
Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014.
J Neurol, 262: 1828-1836, 2015
44.Ohmori H, Hara A, Ishikawa K, Mizusawa H, Ando Y:
Clinical characteristics of combined cases of spinocerebellar ataxia types 6 and 31.
J Neurogenet, 29: 80-84, 2015
45.Takeshima T, Sakai F, Suzuki N, Shimizu T, Igarashi H, Araki N, Mnaka S, Nakashima H, Hashimoto Y, Iwata M, Fukuuchi Y:
A simple migraine screening instrument: validation study in Japan.
日本頭痛学会誌, 42: 134-143, 2015
46.Kamada M, Nakane S, Matsui N, Higuchi O, Sakai W, Fujita K, Izumi Y, Matsuo H, Kaji R:
Ocular myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies: Two new cases and a systematic literature review.
Clin Exp Neuroimmunol, 7: 168-173, 2016
47.Kawano H, Bivard A, Lin L, Spratt N, Miteff F, Parsons M, Levi C:
The relationship between collateral status, contrast transit and contrast density in acute ischemic stroke.
Stroke, 47: 742-749, 2016
48.Kawano H, Levi C, Inatomi Y, Pagram H, Kerr E, Bivard A, Spratt N, Miteff F, Yonehara T, Ando Y, Parsons M:
International benchmarking for acute thrombolytic therapy implementation: Australia and Japan.
J Clin Neurosci, 29: 87-91, 2016
49.Ando Y, Chiba S, Capasso R, Okushi T, Kojima H, Otori N, Wada K:
Risk factors for sleep impairment in adult patients with chronic rhinosinusitis.
Auris Nasus Larynx, 43: 418-421, 2016
50.Ando Y, Sekijima Y, Obayashi K, Yamashita T, k8, Misumi Y, Morita H, Machii K, Ohta M, Takata A, Ikeda S:
Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Varl30Met: A phase III, open-label study.
J Neurol Sci, 362: 266-271, 2016
51.Asakura K, Yanai S, Nakamura S, Kawasaki K, Eizuka M, Ishida K, Sugai T, Ueda M, Yamashita T, Ando Y, Matsumoto T:
Endoscopic findings of small-bowel lesions in familial amyloid polyneuropathy: A Case Report.
Medicine, 95: 2896, 2016
52.Azuma M, Hirai T, Yamada K, Yamashita S, Ando Y, Tateishi M, Iryo Y, Yoneda T, Kitajima M, Wang Y, Yamashita Y:
Lateral asymmetry and spatial difference of iron deposition in the substantia nigra of Parkinson’s disease patients measured with quantitative susceptibility mapping.
AJNR Am J Neuroradiol, 37: 782-788, 2016
53.Kuki I, Kawawaki H, Okazaki S, Hattori Y, Horino A, Higuchi O, Nakane S:
Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis.
Brain Dev, 38: 605-608, 2016
54.Kukidome D, Nishikawa T, Sato M, Igata M, Kawashima J, Shimoda S, Matsui K, Obayashi K, Ando Y, Araki E:
Measurement of small-fiber pain threshold values for the early detection of diabetic polyneuropathy.
Diabet Med, 33: 62-69, 2016
55.Kuraoka M, Kimura E, Nagata T, Okada T, Aoki Y, Tachimori H, Yonemoto N, Imamura M, Takeda S:
Serum osteopontin as a novel biomarker for muscle regeneration in Duchenne muscular dystrophy.
Am J Path, 186: 1302-1312, 2016
56.Maeda Y, Migita K, Higuchi O, Mukaino A, Furukawa H, Komori A, Nakamura M, Hashimoto S, Nagaoka S, Abiru S, Yatsuhashi H, Matsuo H, Kawakami A, Yasunami M, Nakane S:
Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.
PLoS One, 11: e0146048, 2016
57.Masuda T, Obayashi K, Ueda M, Fujimoto A, Tasaki M, Misumi Y, Ueda A, Nakane S, Yamashita T, Ando Y:
Therapeutic effects and prevention of recurrence of acquired idiopathic generalized anhidrosis via i.v. immunoglobulin treatment.
J Dermatol, 43: 336-337, 2016
58.Misumi Y, Narita Y, Oshima T, Ueda M, Yamashita T, Tasaki M, Obayashi K, Isono K, Inomata Y, Ando Y:
Recipient aging accelerates acquired transthyretin amyloidosis after domino liver transplantation.
Liver Transpl, 22: 656-664, 2016
59.Mori A, Yamashita S, Nakajima M, Hori H, Tawara A, Matsuo Y, Misumi Y, Ando Y:
CMAPdecrement as a potential diagnostic marker for ALS.
Acta Neurol. Scand, 134: 49-53, 2016
60.Nishikawa A, Mori-Yoshimura M, Segawa K, Hayashi YK, Takahashi T, Saito Y, Nonaka I, Krahn M, Levy N, Shimizu J, Kimura E, Goto J, Yonemoto N, Aoki M, Nishino I, Oya Y, Murata M:
Respiratory and cardiac function in Japanese patients with dysferlinopathy.
Muscle nerve, 53: 394-401, 2016
61.Okumura K, Yamashita T, Masuda T, Misumi Y, Ueda A, Ueda M, Obayashi K, Jono H, Yamashita S, Inomata Y, Ando Y:
Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
Amyloid, 23: 39-45, 2016
62.Shindo S, Fujii K, Shirakawa M, Uchida K, Sugiura Y, Saito S, Ando Y, Yoshimura S:
Three-dimensional optical frequency domain imaging evaluation of novel dual-layered carotid stent implantation for vulnerable carotid plaque.
J Stroke Cerebrovasc Dis, 25: e31-e32, 2016
63.Suzuki T, Kusumoto S, Yamashita T, Masuda A, Kinoshita S, Yoshida T, Takami-Mori F, Takino H, Ito A, Ri M, Ishida T, Komatsu H, Ueda M, Ando Y, Inagaki H, Iida S:
Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.
Ann Hematol, 95: 279-285, 2016
64.Tasaki M, Ueda M, Obayashi K, Motokawa H, Kinoshita Y, Suenaga G, Yanagisawa A, Toyoshima R, Misumi Y, Masuda T, Yamashita T, Ando Y:
Rapid detection of wild-type and mutated transthyretins.
Ann Clin Biochem, 53: 508-510, 2016
65.Tokunaga M, Beppu A, Tamura Y, Oowaki K, Tokunaga Y, Ishihara C, Shibata K, Tanaka K, Takayama M:
Relationship between improvement in GNRI, a nutritional index, and improvement in motor FIM in elderly stroke patients hospitalized in a Kaifukuki Rehabilitation Ward.
Jpn J Compr Rehabil Sci, 7: 7-12, 2016
66.Tokunaga M, Mori Y, Ogata Y, Tanaka Y, Uchino K, Maeda Y, Kamiyoshi M:
Predicting FIM gain in stroke patients by adding median FIM gain stratified by FIM score at hospital admission to the explanatory variables in multiple regression analysis –An analysis of the Japan Rehabilitation Detabase-.
Jpn J Compr Rehabil Sci, 7: 13-18, 2016
67.Yanagisawa A, Ueda M, Sueyoshi T, Nakamura E, Tasaki M, Suenaga G, Motokawa H, Toyoshima R, Kinoshita Y, Misumi Y, Yamashita T, Sakaguchi M, Westermark P, Mizuta H, Ando Y:
Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid.
Amyloid, 23: 26-32, 2016
68.Yoshimura Y, Kuwabara T, Shiraishi T, Kakizoe Y, Tasaki M, Obayashi K, Ando Y, Mukoyama M:
Transthyretin-related familial amyloid polyneuropathy found with abnormal urinalysis at a general health checkup.
Nephrology, 21: 341-342, 2016
69.Kimura T, Fukushima S, Miyashita A, Aoi J, Jinnin M, Kosaka T, Ando Y, Matsukawa M, Inoue H, Kiyotani K, Park JH, Nakamura Y, Ihn H:
Myasthenic crisis and polymyositis induced by one dose of nivolumab.
Cancer Sci, 107: 1055-1058, 2016
70.Jono H, Su Y, Obayashi K, Tanaka Y, Ishiguro A, Nishimura H, Shinriki S, Ueda M, Ikeda K, Yamagata K, Ichihara K, Ando Y;
Scientific Committee for the Asia-Pacific Federation of Clinical Biochemistry: Sources of variation of transthyretin in healthy subjects in East and Southeast Asia: Clinical and experimental evidence for the effect of alcohol on transthyretin metabolism.
Clin Chim Acta, 458: 5-11, 2016
71.Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL:
Rationale, application, and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.
Leukemia, 30: 1979-1986, 2016
72.Mukaino A, Nakane S, Higuchi O, Nakamura H, Miyagi T, Shiroma K, Tokashiki T, Fuseya Y, Ochi K, Umeda M, Nakazato T, Akioka S, Maruoka H, Hayashi M, Igarashi SI, Yokoi K, Maeda Y, Sakai W, Matsuo H, Kawakami A:
Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren’s syndrome.
Mod Rheumatol, 26: 708-715, 2016
73.Nakane S, Izumi Y, Oda M, Kaji R, Matsuo H:
A possible link between amyotrophic lateral sclerosis and bullous pemphigoid: six new cases and a systematic review of the literature.
Intern Med, 55: 1985-1990, 2016
74.Takeuchi F, Komaki H, Nakamura H, Yonemoto N, Kashiwabara K, Kimura E, Takeda S:
Trends in steroid therapy for Duchenne muscular dystrophy in Japan.
Muscle Nerve, 54: 673-680, 2016